Diagnostic significance of immunoglobulin G avidity in symptomatic and asymptomatic West Nile virus infection. 2018

Tatjana Vilibic-Cavlek, and Branimir Kristofic, and Vladimir Savic, and Branko Kolaric, and Ljubo Barbic, and Irena Tabain, and Ljiljana Peric, and Dario Sabadi, and Bozana Miklausic, and Tanja Potocnik-Hunjadi, and Sanja Zember, and Vladimir Stevanovic, and Eddy Listes, and Giovanni Savini
Department of Virology, Croatian Institute of Public Health, Zagreb, Croatia.

BACKGROUND West Nile virus (WNV) immunoglobulin M (IgM) antibodies have been shown to persist for up to 500 days in certain patients. To evaluate the usefulness of immunoglobulin G (IgG) avidity assessment in the diagnosis of WNV infection, we analyzed 54 WNV IgM- and/or IgG-positive serum samples from 39 patients with neuroinvasive disease and 15 asymptomatic cases tested during a seroprevalence investigation. METHODS Serological tests (WNV IgM/IgG antibody detection, IgG avidity) were performed using commercially available enzyme-linked immunosorbent assays. RESULTS WNV IgM antibodies were detected in 47 (87%) samples. Acute/recent WNV infection was confirmed based on low/borderline avidity index (AI) in 44 IgM-positive samples (93.6%). In three IgM-positive samples (6.4%), high IgG AIs were detected, thus indicating persisting IgM antibodies from previous infections. All IgM-negative samples showed high AIs. Patients with WNV neuroinvasive disease tested within 30 days showed low AIs. In six patients tested 34-50 days after disease onset, AI was borderline (42%-60%), suggesting earlier WNV IgG maturation. Samples with the highest IgM values were associated with the lowest AIs (Spearman's rho coefficient -0.767, p < 0.001). CONCLUSIONS Our results indicate that IgG avidity differentiates current/recent WNV infection from persistent IgM seropositivity from the previous WNV transmission season both in patients with WNV neuroinvasive disease and in asymptomatic persons. A strong negative correlation between IgM antibody levels and AI indicates that in cases with very high IgM levels, determination of IgG avidity may not be necessary. As many patients showed rapid avidity maturation, low IgG avidity is indicative of WNV infection within the previous month.

UI MeSH Term Description Entries
D007074 Immunoglobulin G The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B. Gamma Globulin, 7S,IgG,IgG Antibody,Allerglobuline,IgG(T),IgG1,IgG2,IgG2A,IgG2B,IgG3,IgG4,Immunoglobulin GT,Polyglobin,7S Gamma Globulin,Antibody, IgG,GT, Immunoglobulin
D007075 Immunoglobulin M A class of immunoglobulin bearing mu chains (IMMUNOGLOBULIN MU-CHAINS). IgM can fix COMPLEMENT. The name comes from its high molecular weight and originally was called a macroglobulin. Gamma Globulin, 19S,IgM,IgM Antibody,IgM1,IgM2,19S Gamma Globulin,Antibody, IgM
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000914 Antibodies, Viral Immunoglobulins produced in response to VIRAL ANTIGENS. Viral Antibodies
D000915 Antibody Affinity A measure of the binding strength between antibody and a simple hapten or antigen determinant. It depends on the closeness of stereochemical fit between antibody combining sites and antigen determinants, on the size of the area of contact between them, and on the distribution of charged and hydrophobic groups. It includes the concept of "avidity," which refers to the strength of the antigen-antibody bond after formation of reversible complexes. Affinity, Antibody,Antibody Avidity,Avidity, Antibody,Affinities, Antibody,Antibody Affinities,Antibody Avidities,Avidities, Antibody
D012621 Seasons Divisions of the year according to some regularly recurrent phenomena usually astronomical or climatic. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed) Seasonal Variation,Season,Seasonal Variations,Variation, Seasonal,Variations, Seasonal
D014901 West Nile Fever A mosquito-borne viral illness caused by the WEST NILE VIRUS, a FLAVIVIRUS and endemic to regions of Africa, Asia, and Europe. Common clinical features include HEADACHE; FEVER; maculopapular rash; gastrointestinal symptoms; and lymphadenopathy. MENINGITIS; ENCEPHALITIS; and MYELITIS may also occur. The disease may occasionally be fatal or leave survivors with residual neurologic deficits. (From Joynt, Clinical Neurology, 1996, Ch26, p13; Lancet 1998 Sep 5;352(9130):767-71) Kunjin virus Infection,Encephalitis, West Nile Fever,WNV Infection,West Nile Fever Encephalitis,West Nile Fever Meningitis,West Nile Fever Meningoencephalitis,West Nile Fever Myelitis,West Nile Virus Infection,Infection, Kunjin virus,Infection, WNV,Kunjin virus Infections,WNV Infections
D014902 West Nile virus A species of FLAVIVIRUS, one of the Japanese encephalitis virus group (ENCEPHALITIS VIRUSES, JAPANESE). It can infect birds and mammals. In humans, it is seen most frequently in Africa, Asia, and Europe presenting as a silent infection or undifferentiated fever (WEST NILE FEVER). The virus appeared in North America for the first time in 1999. It is transmitted mainly by CULEX spp mosquitoes which feed primarily on birds, but it can also be carried by the Asian Tiger mosquito, AEDES albopictus, which feeds mainly on mammals. Egypt 101 virus,Kunjin virus

Related Publications

Tatjana Vilibic-Cavlek, and Branimir Kristofic, and Vladimir Savic, and Branko Kolaric, and Ljubo Barbic, and Irena Tabain, and Ljiljana Peric, and Dario Sabadi, and Bozana Miklausic, and Tanja Potocnik-Hunjadi, and Sanja Zember, and Vladimir Stevanovic, and Eddy Listes, and Giovanni Savini
January 2006, Clinical and vaccine immunology : CVI,
Tatjana Vilibic-Cavlek, and Branimir Kristofic, and Vladimir Savic, and Branko Kolaric, and Ljubo Barbic, and Irena Tabain, and Ljiljana Peric, and Dario Sabadi, and Bozana Miklausic, and Tanja Potocnik-Hunjadi, and Sanja Zember, and Vladimir Stevanovic, and Eddy Listes, and Giovanni Savini
December 2005, Journal of clinical microbiology,
Tatjana Vilibic-Cavlek, and Branimir Kristofic, and Vladimir Savic, and Branko Kolaric, and Ljubo Barbic, and Irena Tabain, and Ljiljana Peric, and Dario Sabadi, and Bozana Miklausic, and Tanja Potocnik-Hunjadi, and Sanja Zember, and Vladimir Stevanovic, and Eddy Listes, and Giovanni Savini
November 2004, Journal of clinical microbiology,
Tatjana Vilibic-Cavlek, and Branimir Kristofic, and Vladimir Savic, and Branko Kolaric, and Ljubo Barbic, and Irena Tabain, and Ljiljana Peric, and Dario Sabadi, and Bozana Miklausic, and Tanja Potocnik-Hunjadi, and Sanja Zember, and Vladimir Stevanovic, and Eddy Listes, and Giovanni Savini
January 2006, The Journal of experimental medicine,
Tatjana Vilibic-Cavlek, and Branimir Kristofic, and Vladimir Savic, and Branko Kolaric, and Ljubo Barbic, and Irena Tabain, and Ljiljana Peric, and Dario Sabadi, and Bozana Miklausic, and Tanja Potocnik-Hunjadi, and Sanja Zember, and Vladimir Stevanovic, and Eddy Listes, and Giovanni Savini
June 1992, Journal of clinical microbiology,
Tatjana Vilibic-Cavlek, and Branimir Kristofic, and Vladimir Savic, and Branko Kolaric, and Ljubo Barbic, and Irena Tabain, and Ljiljana Peric, and Dario Sabadi, and Bozana Miklausic, and Tanja Potocnik-Hunjadi, and Sanja Zember, and Vladimir Stevanovic, and Eddy Listes, and Giovanni Savini
July 2003, The Journal of infectious diseases,
Tatjana Vilibic-Cavlek, and Branimir Kristofic, and Vladimir Savic, and Branko Kolaric, and Ljubo Barbic, and Irena Tabain, and Ljiljana Peric, and Dario Sabadi, and Bozana Miklausic, and Tanja Potocnik-Hunjadi, and Sanja Zember, and Vladimir Stevanovic, and Eddy Listes, and Giovanni Savini
January 2020, Frontiers in immunology,
Tatjana Vilibic-Cavlek, and Branimir Kristofic, and Vladimir Savic, and Branko Kolaric, and Ljubo Barbic, and Irena Tabain, and Ljiljana Peric, and Dario Sabadi, and Bozana Miklausic, and Tanja Potocnik-Hunjadi, and Sanja Zember, and Vladimir Stevanovic, and Eddy Listes, and Giovanni Savini
March 2005, AJR. American journal of roentgenology,
Tatjana Vilibic-Cavlek, and Branimir Kristofic, and Vladimir Savic, and Branko Kolaric, and Ljubo Barbic, and Irena Tabain, and Ljiljana Peric, and Dario Sabadi, and Bozana Miklausic, and Tanja Potocnik-Hunjadi, and Sanja Zember, and Vladimir Stevanovic, and Eddy Listes, and Giovanni Savini
June 2004, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists,
Tatjana Vilibic-Cavlek, and Branimir Kristofic, and Vladimir Savic, and Branko Kolaric, and Ljubo Barbic, and Irena Tabain, and Ljiljana Peric, and Dario Sabadi, and Bozana Miklausic, and Tanja Potocnik-Hunjadi, and Sanja Zember, and Vladimir Stevanovic, and Eddy Listes, and Giovanni Savini
September 2004, Zhonghua er ke za zhi = Chinese journal of pediatrics,
Copied contents to your clipboard!